Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mylan Technologies, a subsidiary of Viatris, is a specialized pharmaceutical company focused on the development and manufacturing of transdermal and mucosal drug delivery systems. Based in St. Albans, Vermont, the company is a global leader in patch technology, producing complex generics and branded products for various therapeutic areas including pain management and hormonal therapy. Their expertise spans from early-stage R&D to large-scale commercial manufacturing under GMP standards. Mylan Technologies provides both internal product support for Viatris and contract manufacturing services for external partners. The facility is a major employer in the region and maintains rigorous compliance with DEA regulations for controlled substances.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mylan Technologies.